Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lydia Meziani

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|June 30, 2025
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effectPierre-Antoine Laurent, Liu Shi, Lisa Bouarroudj, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 18, 2024
Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck CarcinomaAlessandra Gonnelli, Marine Gerbé de Thoré, Maria Laura Ermini, et al.
International Journal of Molecular Sciences|February 25, 2023
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged TissuesStéphanie Solier, Michele Mondini, Lydia Meziani, et al.
Molecular Cancer|March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancerAntonin Levy, Daphné Morel, Matthieu Texier, et al.
Signal Transduction and Targeted Therapy|March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial resultsAntonin Levy, Daphné Morel, Matthieu Texier, et al.
Cancer Cell|March 11, 2025
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patientsJianzhou Chen, Antonin Levy, Ai-Ling Tian, et al.
Cancer Discovery|February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsJean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.
Cell Death and Differentiation|July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisAnne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal for Immunotherapy of Cancer|June 30, 2025
Low-dose radiotherapy enhances the efficacy of PD-L1 blockade and induces the abscopal effectPierre-Antoine Laurent, Liu Shi, Lisa Bouarroudj, et al.
Advanced Materials (Deerfield Beach, Fla.)|May 18, 2024
Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck CarcinomaAlessandra Gonnelli, Marine Gerbé de Thoré, Maria Laura Ermini, et al.
International Journal of Molecular Sciences|February 25, 2023
Caspase Inhibition Modulates Monocyte-Derived Macrophage Polarization in Damaged TissuesStéphanie Solier, Michele Mondini, Lydia Meziani, et al.
Molecular Cancer|March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancerAntonin Levy, Daphné Morel, Matthieu Texier, et al.
Signal Transduction and Targeted Therapy|March 18, 2025
Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial resultsAntonin Levy, Daphné Morel, Matthieu Texier, et al.
Cancer Cell|March 11, 2025
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patientsJianzhou Chen, Antonin Levy, Ai-Ling Tian, et al.
Cancer Discovery|February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsJean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.
Cell Death and Differentiation|July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisAnne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.
Pageof 3